Printer Friendly

Articles from M2 Pharma (June 29, 2018)

1-22 out of 22 article(s)
Title Author Type Words
Adicet Bio Names New Chief Scientific Officer. 192
American Regent unveils US FDA approved Hydroxyprogesterone Caproate Injection, USP. 136
Amgen Releases Results From Phase 3 Study of its Biosimilar Candidate for Rheumatoid Arthritis. 213
Array BioPharma's Braftovi (encorafenib) capsule and Mektovi (binimetinib) tablet combination approved by US FDA. 181
AstraZeneca and Merck reveal positive results from Phase III SOLO-1 Lynparza trial. 209
Bayer launches heart failure research collaboration with Broad Institute. 278
Berlin Cures Adds First Two Members to Newly Created Business Advisory Board. 274
Bill & Melinda Gates Foundation provides grant of USD267,870 to Southwest Research Institute. 255
Carisma Therapeutics Closes Series A Financing to Develop Proprietary Cellular Immunotherapy. 148
Doximity Reveals Potential Upcoming OB-GYN Shortage. 238
Episurf Medical ready to file IDE application to the US FDA for the Episealer knee implant. 177
Ginkgo Bioworks Active in US Biosecurity Initiative to Reduce Global Biological Threats. 241
Juntendo University Research Reveals a Triggering Mechanism for Certain Cancers. 234
KEPRO appoints Srinivas Achukola as CTO. 155
Lumicks collaborates with AstraZeneca and the University of Cambridge Biochemistry Department. 169
Matas reports on annual general meeting. 404
Medivir reports positive top-line results from the MIV-711 osteoarthritis phase IIa extension study. Report 336
Novartis plans Alcon spinoff. 224
Pivot Pharma Applying for Human Trials in Topical Cannabinoid for Female Sexual Dysfunction. 173
SwRI wins Bill & Melinda Gates Foundation grant to reduce the cost of current malaria treatment. 215
Transparency Market Research Values Immunoassay Market at USD 28bn by 2026. 302
US FDA Gives 510(k) Clearance for High-sensitivity Troponin I Assay. 245

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters